To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials

  • Lisa McManus, Jill A. Fisher
  • AJOB Empirical Bioethics, April 2018, Taylor & Francis
  • DOI: 10.1080/23294515.2018.1469552

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/23294515.2018.1469552